高级检索
当前位置: 首页 > 详情页

6-Gingerol attenuates arsenic trioxide-induced liver injury by inhibiting pyroptosis and ROS-NLRP3 inflammatory signaling pathway: Based on network pharmacology analysis and experiment verification

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China [2]Hebei Univ Chinese Med, Sch Pharm, Shijiazhuang, Hebei, Peoples R China [3]Hebei Med Univ, Sch Pharm, Shijiazhuang, Hebei, Peoples R China [4]Hebei Key Lab Integrat Med Liver Kidney Patterns, Shijiazhuang, Hebei, Peoples R China [5]Hebei Univ Chinese Med, Affiliated Hosp, Shijiazhuang, Hebei, Peoples R China [6]Hebei Univ Chinese Med, Sch Basic Med, Shijiazhuang, Hebei, Peoples R China [7]Hebei Univ Chinese Med, Sch Integrat Med, Shijiazhuang, Hebei, Peoples R China
出处:
ISSN:

关键词: 6-gingerol Arsenic trioxide Liver injury Network pharmacology Pyroptosis Inflammation

摘要:
6-Gingerol (6G) is the main phenolic active component of ginger, which has a certain protective effect against liver injury induced by drugs, and chemical pollutants. However, the mechanism of protection of 6G against arsenic trioxide (ATO)-induced liver injury remains unclear. The network pharmacology and animal experiment results respectively indicated that oxidative stress and in-flammatory responses were closely related to ATO-induced liver injury. 6G can alleviate ATO-induced liver injury and oxidative stress. Furthermore, 6G can attenuate the release of pro -inflammatory factors induced by ATO and reduce the expressions of NLRP3, ASC, Caspase-1 and gasdermin-D. The results showed that the activation of NLRP3 inflammatory and its induced pyroptosis play critical roles in liver injury caused by ATO. Furthermore, 6G can suppress the ROS-NLRP3 inflammasome signaling pathway, which may be an effective strategy for the treatment of ATO-induced liver injury.

基金:
语种:
被引次数:
WOS:
中科院分区:
出版当年[2023]版:
大类 | 2 区 农林科学
小类 | 2 区 食品科技 3 区 营养学
最新[2025]版:
大类 | 2 区 农林科学
小类 | 3 区 食品科技 4 区 营养学
JCR分区:
出版当年[2023]版:
Q2 FOOD SCIENCE & TECHNOLOGY Q2 NUTRITION & DIETETICS
最新[2024]版:
Q2 FOOD SCIENCE & TECHNOLOGY Q2 NUTRITION & DIETETICS

影响因子: 最新[2024版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版] 出版后一年[2024版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [2]Hebei Univ Chinese Med, Sch Pharm, Shijiazhuang, Hebei, Peoples R China [4]Hebei Key Lab Integrat Med Liver Kidney Patterns, Shijiazhuang, Hebei, Peoples R China [5]Hebei Univ Chinese Med, Affiliated Hosp, Shijiazhuang, Hebei, Peoples R China [6]Hebei Univ Chinese Med, Sch Basic Med, Shijiazhuang, Hebei, Peoples R China [7]Hebei Univ Chinese Med, Sch Integrat Med, Shijiazhuang, Hebei, Peoples R China [*1]School of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China [*2]Affiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号